|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Impairment of long-term assets | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income (expense) | |||||
| Unrealized gain on marketable securities | |||||
| Extinguishment of payables | |||||
| Interest and other income, net | |||||
| Total other income | |||||
| Net income/(loss) | |||||
| Net loss | |||||
| Earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in computing earnings per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...